More targeted state aid measures, the reduction of administrative burden for small and medium-sized enterprises (SMEs), more information on alternative financing opportunities and enhanced financial reporting of enterprises – these recommendations and measures of their implementation have been presented by the Bank of Lithuania and the...
The Lithuanian competition authority Konkurencijos taryba has cleared the acquisition of joint control of InMedica and, indirectly, MediCA klinika , Kardiolita , Bendrosios medicinos praktika and Svalbono klinika by the investment fund INVL Baltic Sea Growth Fund and the companies Litgaja and RP PHARMA on condition that part of the...
In relation to the amendments to the Law on Competition adopted by the Seimas, today the Lithuanian competition authority Konkurencijos taryba has updated the Leniency Rules and adopted the Rules on Cooperation with the EU Competition Authorities or Other Counterparts.
The Lithuanian competition authority Konkurencijos taryba has adopted the guidance indicating the main principles and criteria used when assessing if an undertaking holds a dominant position, as well as its position in the relevant market, i.e. market power. The Explanations concerning the assessment of a dominant position will enter into...
From July 1 persons who provide evidence enabling Konkurencijos taryba to detect anti-competitive agreements will be entitled to a financial reward. It is hoped that this will encourage the society to take a more active role in reporting to the Lithuanian competition authority cartels or other anti-competitive agreements entered into by the...
The Lithuanian Competition Council closed the investigation into the compliance of Swedbank actions with the requirements of the Law on Competition upon Swedbank submitting written commitments suitable for the elimination of the alleged competition law breach and creating preconditions to avoid it in the future.
The Competition Council (hereinafter – KT) has submitted its preliminary market study report on reimbursable pharmaceuticals for public consultation. KT experts aimed at finding out if current legal regulation does not create obstacles for pharmaceuticals to enter the market of reimbursable pharmaceuticals and stay in it, and whether competition...